INFI 25mg (Truseltiq 25 mg)
Generic Name: infigratinib
Pill with imprint INFI 25mg is Gray & White, Capsule-shape and has been identified as Truseltiq 25 mg. It is supplied by BridgeBio Pharma, Inc.
Truseltiq is used in the treatment of biliary tract tumor and belongs to the drug class multikinase inhibitors. Truseltiq 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for INFI 25mg
Truseltiq
- Generic Name
- infigratinib
- Imprint
- INFI 25mg
- Strength
- 25 mg
- Color
- Gray & White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- BridgeBio Pharma, Inc.
- National Drug Code (NDC)
- 72730-0506
More about Truseltiq (infigratinib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Imprints, shape & color data
- Pricing & coupons
- En español
- Drug class: multikinase inhibitors
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.